Home / Companies / Interviews / Challenge will be making sure Covid-19 vaccine efficacy is high: Serum CEO

Challenge will be making sure Covid-19 vaccine efficacy is high: Serum CEO

The data from the trials and the vaccinated groups will show the levels of efficacy from the Oxford project, says Adar Poonawalla

Premium

Adar Poonawalla, CEO, Serum Institute

3 min read Last Updated : Apr 29 2020 | 8:47 AM IST

Adar Poonawalla, chief executive officer of Serum Institute of India — the world’s largest manufacturer of vaccines by volume — has said his biotechnology firm, in partnership with an Oxford University-led consortium, will roll out a coronavirus disease (Covid-19) vaccine before the end of this year. Poonawalla tells Pavan Lall that he will be setting up a factory so that work can begin as soon as approvals and clinical trials are wrapped up. Edited excerpts:

You are planning to make the vaccine available at Rs 1,000. Isn’t that high for millions of low-income households?

We are going to supply the

Topics : Coronavirus Healthcare in India healthcare technologies

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in